<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>65(Pt 7)</volume><submitter>Tailor D</submitter><pubmed_abstract>The title compound, C(16)H(22)N(2)O(3), was synthesized during the course of a study on (1R,2S)-norephedrine-derived 1,3,4-oxadiazinan-2-ones. The conformation adopted by the isopropyl group is pseudo-axial relative to the oxadiazinan core. The allylic strain contributes to this conformational arrangement.</pubmed_abstract><journal>Acta crystallographica. Section E, Structure reports online</journal><pagination>o1685-6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2969394</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>(5R,6S)-4-Isopropyl-5-methyl-6-phenyl-3-propanoyl-2H-1,3,4-oxadiazinan-2-one.</pubmed_title><pmcid>PMC2969394</pmcid><pubmed_authors>Hitchcock SR</pubmed_authors><pubmed_authors>Ferrence GM</pubmed_authors><pubmed_authors>Tailor D</pubmed_authors><pubmed_authors>Edler KL</pubmed_authors><pubmed_authors>Casper DM</pubmed_authors></additional><is_claimable>false</is_claimable><name>(5R,6S)-4-Isopropyl-5-methyl-6-phenyl-3-propanoyl-2H-1,3,4-oxadiazinan-2-one.</name><description>The title compound, C(16)H(22)N(2)O(3), was synthesized during the course of a study on (1R,2S)-norephedrine-derived 1,3,4-oxadiazinan-2-ones. The conformation adopted by the isopropyl group is pseudo-axial relative to the oxadiazinan core. The allylic strain contributes to this conformational arrangement.</description><dates><release>2009-01-01T00:00:00Z</release><publication>2009 Jun</publication><modification>2021-02-21T03:16:05Z</modification><creation>2019-03-27T00:00:09Z</creation></dates><accession>S-EPMC2969394</accession><cross_references><pubmed>21582942</pubmed><doi>10.1107/S1600536809022363</doi></cross_references></HashMap>